Cytokine IL-36γ Improves CAR T Cell Functionality and Induces Endogenous Anti-Tumor Response

por Li, Xinghuo, Daniyan, Anthony F., Lopez, Andrea V., Purdon, Terence J., Brentjens, Renier J.
Publicado 2020

CD103(+) cDC1 and endogenous CD8(+) T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function

por Kuhn, Nicholas F., Lopez, Andrea V., Li, Xinghuo, Cai, Winson, Daniyan, Anthony F., Brentjens, Renier J.
Publicado 2020

Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System

por Avanzi, Mauro P., Yeku, Oladapo, Li, Xinghuo, Wijewarnasuriya, Dinali P., van Leeuwen, Dayenne G., Cheung, Kenneth, Park, Hyebin, Purdon, Terence J., Daniyan, Anthony F., Spitzer, Matthew H., Brentjens, Renier J.
Publicado 2018